Reform of business processes

During 2014 the TGA continued to improve its business processes by :

• Clarifying requirements for sponsors of complementary medicines
• Improving the electronic listing facility to increase useability and provide additional information to applicants

We continue to work on improvements to:

• Further develop risk profiles to more efficiently manage compliance reviews of listed complementary medicines
• Improve the market authorisation processes for registered complementary medicines and new substances (ingredients)
• Improve stakeholders' understanding of the regulatory framework for complementary medicines, particularly through engagement with industry.

Reforms including those stemming from the Auditor-General's Report on Therapeutic Goods Regulation: Complementary Medicines have now been achieved, for example, the TGA has published its updated Australian Regulatory Guidelines for Complementary Medicines and the revised Guidelines on the evidence required to support indications for listed complementary medicines and publishes cancellations of listed complementary medicines following compliance review.

The TGA will continue to progress improvements to business processes including streamlining of applications for registered complementary medicines and new substances for use in listed medicines.

Performance reporting

The TGA reports to stakeholders at six monthly intervals on our progress in delivery against a set of agreed performance reporting KPIs. The KPIs are high-level indicators for the TGA's overall performance against our broad strategic intent. Within that matrix of KPIs is a requirement for measuring whether 'business operations are consistent and meet agreed service and timeliness standards'. Measures of specific business activities will continue to be documented in our half-yearly performance reports. For more information on the TGA's KPI's please visit TGA key performance indicators.